Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas

Modern Pathology

Volumn 12, Issue 8, 1999, Pages 786-793

  Busam, Klaus J ^a   Tan, Lee K ^a,e   Granter, Scott R ^b   Kohler, Sabine ^c   Junkins Hopkins, Jacqueline ^d   Berwick, Marianne ^a   Rosen, Paul P ^a,f  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c STANFORD UNIVERSITY   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e BETH ISRAEL MEDICAL CENTER   (United States)

^f White Plains Hospital Center   (United States)

Author keywords

Breast carcinoma; EGF R; ER; Metastasis; PR; Sweat gland carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; APOCRINE GLAND; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN METASTASIS; SWEAT GLAND CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SKIN NEOPLASMS; SWEAT GLAND NEOPLASMS;

EID: 0032841004     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. J Am Acad Dermatol 1990;22:19-26.
2. Lookingbill DP, Spangler N, Helm HF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993;29:228-36.
3. Swanson PE, Mazoujian G, Mills SE, Campbell RJ, Wick MR. Immunoreactivity for estrogen receptor protein in sweat gland tumors. Am J Surg Pathol 1991;15:835-41.
4. Tsubara A, Senzaki H, Sasaki M, Hilgers J, Morii S. Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors. J Cutan Pathol 1992;19:73-9.
5. Wallace ML, Longacre TA, Smoller BR. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein (BRST-2) fail to distinguish between metastatic breast carcinoma from eccrine neoplasms. Mod Pathol 1995;8:897-901.
6. Wick MR, Goellner JR, Wolfe JT 3rd, Su WPD. Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer 1985;56: 1147-62.
7. Wick MR, Swanson PE, Barnhill RL. Sweat gland tumors. In: Barnhill RL, editor. Textbook of dermatopathology. New York: McGraw-Hill; 1998. p. 623-56.
8. Mazoujian G, Margolis R. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am J Dermatopathol 1988;10:28-35.
9. Swanson PE, Cherwitz DL, Neumann MP, Wick MR. Eccrine sweat gland carcinoma: a histologic and immunohistochemical study of 32 cases. J Cutan Pathol 1987;14:65-86.
10. Zuk JA, West KP, Fletcher A. Immunohistochemical staining patterns of sweat glands and their neoplasms using two monoclonal antibodies to keratins. J Cutan Pathol 1988;15: 8-17.
11. Nanney LB, McKanna JA, Stoscheck CM, Carpenter G, King LE. Visualization of epidermal growth factor receptor in human epidermis. J Invest Dermatol 1984;82:165-9.
12. Bloom HJG, Richardson WW. Histologic grading and prognosis in breast cancer: a study of 1049 cases, of which 359 have been followed for 15 years. Br J Cancer 1957;11:359-77.
13. Rosen PP. Invasive duct carcinoma and morphologic prognostic markers. In: Rosen PP, editor. Breast pathology. Philadelphia: Lippincott; 1997. p. 275-93.
14. de Almeida PC, Pestana CB. Immunohistochemical markers in the identification of metastatic breast cancer. Breast Cancer Res Treat 1992;21:201-10.
15. Voytek TM, Ricci A Jr, Cartun RW. Estrogen and progesterone receptors in primary eccrine carcinoma. Mod Pathol 1991;4:582-5.
16. Berg JW, McDivitt RW. Pathology of sweat gland carcinoma. Pathol Annu 1968;3:123-44.
17. Derynck R. Transforming growth factor α. Cell 1988;54: 593-5.
18. Downward J, Parker P, Waterfield MD. Autophosphorylation sites on the epidermal growth factor receptor. Nature 1984; 311:483-5.
19. Gill GN, Bertis PJ, Santon JB. Epidermal growth factor and its receptor. Mol Cell Endocrinol 1987;51:169-86.
20. Bauknecht T, Gross G, Hagedorn M. Epidermal growth factor receptors in different skin tumors. Dermatologica 1985;171: 16-20.
21. Bucci B, D'Agnano I, Botti C, Mottolese M, Carico E, Zupi G, et al. EGF-R expression in ductal breast cancer: proliferation and prognostic implications. Anticancer Res 1997;17:769-74.
22. Gohring UJ, Ahr A, Scharl A, Weisner V, Neuhaus W, Crombach G, et al. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma. J Soc Gynecol Investig 1995;2:653-9.
23. Groves RW, Allen MH, MacDonald DM. Abnormal expression of epidermal growth factor in cutaneous epithelial tumors. J Cutan Pathol 1992;19:66-72.
24. Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD. Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res 1986;46:285-92.
25. Helin HJ, Helle MJ, Melin ML, Isola JJ. Immunohistochemical detection of estrogen and progesterone receptors in 124 human breast cancers. Am J Clin Pathol 1988;89:137-42.
26. Higashiyama M, Hashimoto K, Matsumoto K, Yoshikawa K. Differential expression of transforming growth factor α (TGF α) and EGF receptor in transitional area of psoriatic epidermis. J Dermatol Sci 1994;7:45-53.
27. Jonjic N, Kovac K, Krasevic M, Valkovic T, Ernjak N, Sasso F, et al. Epidermal growth factor expression correlates with tumor cell proliferation and prognosis in gastric cancer. Anticancer Res 1997;17:3883-8.
28. Klijn JGM, Berns MJJ, Schmitz PIM, Foekens JA. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review of 5232 patients. Endocr Rev 1992;13:3-17.
29. Lavrijsen APM, Tieben LM, Ponec M, van der Schroeff JG, van Muijen GNP. Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin. Arch Dermatol Res 1989;281:83-8.
30. Nanney LB, Magid M, Stoscheck CM, King LE. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol 1984;83:385-93.
31. Nazmi MN, Dykes PJ, Marks R. Epidermal growth factor receptors in human epidermal tumors. Br J Dermatol 1990; 123:153-61.
32. Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JR, et al. Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet 1985;1:366-8.
33. Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer. Lancet 1987; 1:1398-402.
34. Seshadri R, McLeay WR, Horsfall DJ, McCaul K. Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer. Int J Cancer 1996; 69:23-7.
35. Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ho H, et al. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res 1988;48:137-41.
36. Rodeck U, Jost M, Kari C, Shih DT, Lavker RM, Ewert DL, et al. EGF-R dependent regulation of keratinocyte survival. J Cell Sci 1997;110:113-21.
37. Toi M, Hamada Y, Nakamura T, Mukaida H, Suehiro S, Wada T, et al. Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion. Int J Cancer 1989;43:220-5.
38. Martinazzi M, Crivelli F, Zampatti C, Martinazzi S. Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma. J Clin Pathol 1993;46:1009-10.
39. Schroeder W, Biesterfeld S, Zillessen S, Rath W. Epidermal growth factor receptor: immunohistochemical detection and clinical significance for treatment of primary breast cancer. Anticancer Res 1997;17:2799-802.